Covered recipient · General Payments record
MONIKA G FEALKO
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$2,349.15
- Reported across 119 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $358.17 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $95.49 | 1 |
| ABBVIE INC. | $84.78 | 4 |
| Exact Sciences Corporation | $41.85 | 2 |
| Novo Nordisk AS | $34.66 | 2 |
| Astellas Pharma US Inc | $20.00 | 1 |
| Janssen Pharmaceuticals, Inc | $19.30 | 1 |
| Biogen, Inc. | $19.05 | 1 |
| PFIZER INC. | $16.61 | 1 |
| Abbott Laboratories | $13.24 | 1 |
| Exeltis, USA Inc. | $13.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.24 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125281970 | CMS |
| ABBVIE INC. | $24.47 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716295 | CMS |
| ABBVIE INC. | $26.24 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716297 | CMS |
| ABBVIE INC. | $13.72 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716299 | CMS |
| ABBVIE INC. | $20.35 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103716301 | CMS |
| Astellas Pharma US Inc | $20.00 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139415215 | CMS |
| Biogen, Inc. | $19.05 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104816899 | CMS |
| Exact Sciences Corporation | $21.91 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114654589 | CMS |
| Exact Sciences Corporation | $19.94 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114654595 | CMS |
| Exeltis, USA Inc. | $13.19 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149992833 | CMS |
| Janssen Pharmaceuticals, Inc | $19.30 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078001138 | CMS |
| Medtronic, Inc. | $95.49 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119494380 | CMS |
| Novo Nordisk Inc | $18.45 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097692750 | CMS |
| Novo Nordisk Inc | $16.21 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096615678 | CMS |
| PFIZER INC. | $16.61 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131002381 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.